Bipolar II vs BPD: Episodes, Emotional Reactivity and Diagnostic Overlap
What the evidence actually shows
Evidence Moderate evidence for distinct longitudinal clinical patterns; limited direct bipolar-II-only comparison and no individual diagnostic biomarkerDirect answer
A source-graded review of bipolar II and borderline personality disorder, including hypomania, overlapping symptoms, co-occurrence, assessment and treatment evidence limits. Bipolar II requires a history of hypomania and major depression without a manic episode; everyday mood swings alone do not establish it. [1,3]. BPD involves an enduring pattern across self-image, relationships, behavior and emotion; it cannot be identified from a difficult argument. [2,4]. A systematic review directly compared bipolar disorder and BPD across 28 studies, but bipolar I findings cannot automatically be transferred to bipolar II. [2].
Research brief
Questions this page answers
- Does changing mood several times a day mean bipolar II?
- Can bipolar II and BPD occur together?
- Is hypomania simply being happy or productive?
- Does a mood stabilizer working confirm bipolar disorder?
- Can brain imaging distinguish them in one person?
- Should I stop an antidepressant if I suspect bipolar II?
Signal
Scientific takeaways
- Bipolar II requires a history of hypomania and major depression without a manic episode; everyday mood swings alone do not establish it. [1,3]
- BPD involves an enduring pattern across self-image, relationships, behavior and emotion; it cannot be identified from a difficult argument. [2,4]
- A systematic review directly compared bipolar disorder and BPD across 28 studies, but bipolar I findings cannot automatically be transferred to bipolar II. [2]
- The conditions can co-occur, making an either-or internet checklist unreliable. [1,2,3]
- Treatment evidence differs by diagnosis and outcome; improvement with a medication does not prove which diagnosis is present. [1,3,4,5,6]
Why the same word, mood, creates confusion
Someone can feel devastated after a disagreement, recover when reassured, and become distressed again later that evening. Another person can spend several days sleeping much less than usual, talking more, starting numerous projects and making uncharacteristic decisions. Both experiences may be called a mood swing. That shared phrase does not establish a shared diagnosis. The clinical question is how changes in mood fit into a person's longer history of energy, activity, relationships and functioning. [1,2]
Bipolar II disorder and borderline personality disorder, or BPD, can both involve depression, impulsivity and serious distress. They are also distinct diagnoses that sometimes occur together. This article is a critical narrative synthesis of published reviews, a Cochrane meta-analysis and clinical guidelines, not a new statistical meta-analysis. It cannot determine whether a reader, partner or former partner has either condition.
What bipolar II actually requires
The 2025 World Psychiatry review describes bipolar II as a condition involving at least one hypomanic episode and at least one major depressive episode, without a history of mania. Hypomania means a distinct period of changed mood accompanied by increased energy or activity and associated symptoms. It is not synonymous with irritability, sleeping late, enjoying a night out or having a productive afternoon. [1]
A history of full mania changes the diagnostic formulation toward bipolar I. Conversely, depression without a convincing history of hypomania does not become bipolar II merely because the depression is severe or recurrent. The assessment must establish the episode itself rather than working backward from a preferred label. [1,3]
Clinical evaluation asks about departure from the person's usual baseline, duration, observable changes and consequences. Reduced need for sleep is particularly different from wanting to sleep but being unable to: a person may feel unusually energetic despite substantially less sleep. Even that distinction is one clue among many. Work schedules, substances, medications and medical illness can change sleep and energy for other reasons. [1,3]
What BPD adds to the picture
BPD is assessed as a pervasive pattern involving relationships, identity, emotional regulation and behavior. Some people experience strong sensitivity to perceived abandonment, unstable self-evaluation, chronic emptiness, self-harm or intense anger. No single feature is sufficient. A clinician must consider persistence, impairment, developmental context and other possible explanations. [2,4]
BPD-related changes in affect often arise in interpersonal contexts and may be relatively rapid. However, the internet shortcut that BPD always changes by the hour while bipolar disorder always changes by the week is too rigid. People with bipolar disorder also react to events; people with BPD can have sustained depression. Duration helps organize an assessment but does not replace it. [1,2]
A person can have a valid complaint about rejection or mistreatment regardless of diagnosis. Calling a reaction borderline should never substitute for asking what happened. Equally, an understandable trigger does not excuse intimidation, coercion or violence. Diagnostic work and accountability for conduct answer different questions.
The direct-comparison evidence
Massó Rodriguez and colleagues reviewed 28 studies directly comparing bipolar disorder and BPD: 19 examined clinical features, six neuropsychological performance and three neuroimaging. They found both overlap and distinctions. Impulsivity tended to look more enduring in BPD and more related to clinical state in bipolar samples, while depression, anxiety, trauma histories and suicidal ideation overlapped. [2]
This evidence has an important boundary: bipolar disorder is not a single interchangeable research population. Studies including bipolar I can identify obvious manic differences that are less useful for distinguishing bipolar II from BPD. A finding driven by mania cannot establish the accuracy of a bipolar-II-only diagnostic checklist. Nor does an average group difference tell us how accurately it classifies a person sitting in a clinic. [2]
The three imaging studies are especially insufficient for a commercial claim that a brain scan can settle an uncertain relationship diagnosis. Group-level brain findings can generate hypotheses without becoming routine diagnostic tools. Similar caution applies to online cognitive tests that claim to distinguish the disorders from a few answers.
A comparison that preserves uncertainty
This table scrolls horizontally on small screens. Use Tab to focus the table region, then scroll with arrow keys or touch.
| Assessment question | Why it matters | What it cannot establish alone |
|---|---|---|
| Was there a distinct change in energy, activity and sleep? | Helps reconstruct possible hypomania | A diagnosis from one sleepless night |
| Are emotional changes linked to relationship events? | Clarifies triggers and regulation patterns | That interpersonal sensitivity proves BPD |
| How does the person function between episodes? | Describes longitudinal course | That every symptom-free period excludes BPD |
| Are identity and relationship difficulties persistent? | Adds information beyond mood ratings | That a troubled relationship identifies a personality disorder |
| What changed after medication or substance exposure? | Identifies alternative explanations and risks | That every medication reaction proves bipolarity |
These questions organize information for an assessment. They are not a self-test, a score or instructions for diagnosing someone who has not consented to evaluation.
Both conditions can be present
Co-occurrence matters because treating the problem as a contest between labels can leave part of a person's needs unaddressed. NICE bipolar guidance explicitly recognizes coexisting personality disorders and recommends addressing them alongside bipolar care. A person can need episode prevention, help with relationship instability and support with substance use at the same time. [3]
The existence of overlap also complicates prevalence estimates. A percentage from a specialty clinic may reflect referral patterns, the interview used and the severity of participants. It should not be applied to every person who has depression or to every strained couple. This article therefore does not offer a universal probability that someone with one diagnosis has the other.
Treatment differs, but response does not diagnose
The bipolar II review supports a role for selected mood stabilizers and atypical antipsychotics, alongside psychological and social interventions. It also stresses that bipolar-II-specific evidence is comparatively sparse and sometimes extrapolated from bipolar I or broader depression trials. Different medications and illness phases are not interchangeable. Prescribing requires assessment of benefits, adverse effects, medical conditions and personal preferences. [1]
For BPD, the 2022 Cochrane medication review included 46 randomized trials involving 2,769 participants. Across primary outcomes, it found no clear medication advantage over placebo, with mostly very-low-certainty evidence. This is not evidence that every prescription is useless: treatment of a separately diagnosed condition is a different question. It is evidence against confidently presenting medication as a proven treatment for the entire core BPD pattern. [5]
A later analysis of co-occurring symptoms also found only low- or very-low-certainty evidence. Some symptom-scale results favored specific drug classes, but those findings do not justify a broad claim that drugs resolve BPD relationships or establish the diagnosis from treatment response. Trial populations, exclusions and symptom targets limit inference. [6]
NICE BPD guidance emphasizes structured psychological care rather than using medication specifically for BPD itself. This differs from the central place of medication in bipolar episode management. A patient with both conditions may need both approaches. None of these comparisons provides a safe basis for starting, stopping or borrowing medication. [3,4]
Why screening tools and recollections can mislead
People often seek help during depression and may not recognize previous hypomania as a problem. Conversely, a retrospective description of an energetic week may omit stimulant use, exam pressure, shift work or ordinary excitement. Memories can be informative without being complete. A clinician may ask, with permission, for observations from someone who knew the person during the period in question. [1,3]
A useful personal timeline separates what was observed from what was inferred. For example: “Slept about three hours, said they felt rested, worked on projects overnight for several days” contains more assessable detail than “was obviously manic.” Likewise, “felt terrified when messages stopped and repeatedly asked for reassurance” is more informative than “was being borderline.”
Records can include usual sleep, distinct changes, functioning, medication changes and major stressors. They should not become surveillance of a partner. The purpose is to help the person describe their own experience and seek appropriate care, not to collect ammunition for an argument.
Risk assessment is a separate task
Both conditions can involve substantial suicide risk and functional impairment. A comparison article should not imply that one is the serious diagnosis and the other is merely difficult behavior. Bipolar II is not automatically a mild illness because hypomania is less severe than mania; depressive burden can be considerable. [1]
Severe sleep reduction with escalating risky behavior, psychosis, inability to care for basic needs, or suicidal intent warrants urgent professional assessment. In the United States, call or text 988 for a suicidal or mental-health crisis; use emergency services when there is immediate danger. A diagnosis should never be required before a person can ask for help.
How to use the distinction constructively
An assessment conversation can begin with: “I have repeated depression and periods when my energy and sleep change; could we review the whole pattern?” Another person might say: “My emotions shift sharply during relationship conflict, and I want help understanding the triggers without assuming a diagnosis.” Both requests describe a problem that can be investigated.
Ask what evidence supports the current formulation, what alternatives remain plausible and which outcomes treatment will track. A useful plan can measure sleep stability, distress, work functioning, self-harm and relationship conduct separately. Improvement in one domain is valuable even when other needs remain.
For related context, see BPD versus complex PTSD and emotional dysregulation across diagnoses. The mental-health research hub links the wider collection. The strongest practical use of these articles is preparing a clearer clinical conversation, with room for uncertainty and change over time.
Quick answers
Common questions
Does changing mood several times a day mean bipolar II?
No. Bipolar II requires a longitudinal history including hypomania and major depression. Rapid emotional changes occur in many conditions and are insufficient for diagnosis. [1,2,3]
Can bipolar II and BPD occur together?
Yes. Their overlap is recognized in clinical guidance; a careful assessment can identify both rather than forcing an either-or choice. [1,3,4]
Is hypomania simply being happy or productive?
No. Assessment looks for a distinct change in mood, energy, activity and other symptoms, including the pattern over time and consequences. Ordinary happiness is not hypomania. [1,3]
Does a mood stabilizer working confirm bipolar disorder?
No. Medication response is not an individual diagnostic test, and improvement in a nonspecific symptom cannot establish a particular disorder. [1,2,5]
Can brain imaging distinguish them in one person?
The reviewed imaging literature is too small and heterogeneous to provide a validated routine scan-based distinction for an individual reader. [2]
Should I stop an antidepressant if I suspect bipolar II?
Do not stop or change prescribed medication on the basis of this article. Ask the prescriber to review possible hypomania, adverse effects and the complete longitudinal history. [1,3]
Source ledger
References
6 sources
- 01Bipolar II disorder: a state-of-the-art review Berk M, Corrales A, Trisno R, Dodd S, Yatham LN, Vieta E, McIntyre RS, Suppes T, Agustini B. · 2025Bipolar-II-specific evidence gaps; some treatment evidence extrapolatedComprehensive narrative clinical reviewPMID 40371769DOI 10.1002/wps.21300 PubMed →
- 02Clinical Features, Neuropsychology and Neuroimaging in Bipolar and Borderline Personality Disorder: A Systematic Review of Cross-Diagnostic Studies Massó Rodriguez A, Hogg B, Gardoki-Souto I, Valiente-Gómez A, Trabsa A, Mosquera D, García-Estela A, Colom F, Pérez V, Padberg F, Moreno-Alcázar A, Amann BL. · 2021Mixed bipolar subtypes and mostly group comparisonsSystematic review of 28 cross-diagnostic studiesPMID 34177664DOI 10.3389/fpsyt.2021.681876 PubMed →
- 03Bipolar disorder: assessment and management National Institute for Health and Care Excellence · 2014Clinical recommendations; not a new comparative treatment experimentEvidence-based clinical guideline Source →
- 04Borderline personality disorder: recognition and management National Institute for Health and Care Excellence · 2009Clinical recommendations; not a new comparative treatment experimentEvidence-based clinical guideline Source →
- 05Pharmacological interventions for people with borderline personality disorder Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, Kongerslev MT, Völlm BA, Mattivi JT, Faltinsen E, Todorovac A, Jørgensen MS, Callesen HE, Sales CP, Schaug JP, Simonsen E, Lieb K. · 2022Mostly very-low-certainty evidence for core BPD outcomesCochrane review of 46 randomized medication trialsPMID 36375174DOI 10.1002/14651858.cd012956.pub2 PubMed →
- 06Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses Pereira Ribeiro J, Juul S, Kongerslev MT, Jørgensen MS, Völlm BA, Edemann-Callesen H, Sales C, Schaug JP, Lieb K, Simonsen E, Stoffers-Winterling JM, Storebø OJ. · 2025Low or very low certainty; post hoc co-occurring symptom analysesSecondary Cochrane analysis with updated searchPMID 39428384DOI 10.1192/bjp.2024.172 PubMed →